Earnings History Data for Lineage Cell Therapeutics, Inc. (LCTX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics Inc. is a clinical-stage biotechnology company. It focuses on developing and commercializing therapies for the treatment of degenerative diseases primarily in the United States and internationally. The company's lead product candidates include OpRegen, OPC1 and VAC2 which are in clinical stage. Lineage Cell Therapeutics Inc., formerly known as BioTime Inc., is based in Carlsbad, California.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
10-11-2021 AH 4:05 PM ET
(Nov 10)
LCTX Lineage Cell Therapeutics, Inc. 380.95 -0.05 -0.05 -0.04 Lineage Cell Therapeutics EPS in-line, beats on revenue
[11/10/2021 4:15 PM]
2.49 0.13 
(5.51%)
2.39 0.03 
(1.27%)
1.25 - 3.13 292,774 640,000 14,229
12-08-2021 AH 4:05 PM ET
(Aug 12)
LCTX Lineage Cell Therapeutics, Inc. 385.45 -0.03 -0.03 -0.04 2.61 0.0 
(0.00%)
2.57 -0.04 
(-1.53%)
0.82 - 3.13 376,330 400,000 6,834
13-05-2021 AH 4:05 PM ET
(May 13)
LCTX Lineage Cell Therapeutics, Inc. 361.46 -0.06 -0.04 -0.06 Lineage Cell Therapeutics EPS beats by $0.03, misses on revenue
[5/13/2021 4:10 PM]
2.27 0.10 
(4.38%)
2.26 0.09 
(4.15%)
0.73 - 3.13 713,499 1,190,000 878
11-03-2021 AH 4:05 PM ET
(Mar 11)
LCTX Lineage Cell Therapeutics, Inc. 265.47 0.01 -0.05 -0.03 Lineage Cell Therapeutics EPS beats by $0.03, misses on revenue
[3/11/2021 4:09 PM]
2.50 0.16 
(6.92%)
2.43 0.09 
(3.85%)
0.58 - 3.13 2,398,588 1,880,525 28,439
04-11-2020 AH 4:05 PM ET
(Nov 4)
LCTX Lineage Cell Therapeutics, Inc. 172.48 -0.04 -0.04 -0.04 Lineage Cell Therapeutics EPS misses by $0.01, beats on revenue
[11/4/2020 4:28 PM]
1.32 0.11 
(9.09%)
1.25 0.04 
(3.31%)
0.53 - 1.67 834,907 531,362 3,352
06-08-2020 AH LCTX Lineage Cell Therapeutics, Inc. 127.35 -0.04 -0.04 -0.06 Lineage Cell Therapeutics EPS in-line, misses on revenue
[8/6/2020 4:21 PM]
0.9237 0.03 
(0.40%)
0.95 0.03 
(3.26%)
0.53 - 1.67 364,017 642,863 26,470